U.S. patients seek stem cell treatments in China

06/6/2010 | Washington Post, The

Some U.S. patients with cerebral palsy and other diseases are undergoing experimental stem cell treatments in China, a trend that Western scientists say could jeopardize the health of patients. Moreover, the stem cells used in most clinics in the country are derived from miscarried fetuses, a practice that raises ethical and religious concerns.

View Full Article in:

Washington Post, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA